Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Naafs

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Leprosy Review|January 31, 2004
Treatment duration of reversal reaction: a reappraisal. Back to the pastBen Naafs
Leprosy Review|October 28, 2003
The return of thalidomide: new uses and renewed concerns--replyBen Naafs
Leprosy Review|May 24, 2007
LeprosyBhushan Kumar, Ben Naafs, Sunil Dogra
Leprosy Review|January 31, 2004
Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofaziminePieter A M Schreuder, Ben Naafs
Leprosy Review|April 26, 2013
The leprosy mailing listSunil Deepak, Salvatore Noto, Ben Naafs, et al.
International Journal of Dermatology|January 26, 2013
Guidelines on the role of skin care in the management of mobile populationsLucinda Claire Fuller, Roderick Hay, Aldo Morrone, et al.
Clinics in Dermatology|January 17, 2016
Advances in leprosy immunology and the field application: A gap to bridgeVania Nieto Brito de Souza, Anand M Iyer, David A Lammas, et al.
Plos Neglected Tropical Diseases|January 5, 2011
Granulomatous reactivation during the course of a leprosy infection: reaction or relapseMaria Angela Bianconcini Trindade, Gil Benard, Somei Ura, et al.
Infection and Immunity|April 16, 2002
Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosisAnnemieke Geluk, Krista E van Meijgaarden, Kees L M C Franken, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Leprosy Review|January 31, 2004
Treatment duration of reversal reaction: a reappraisal. Back to the pastBen Naafs
Leprosy Review|October 28, 2003
The return of thalidomide: new uses and renewed concerns--replyBen Naafs
Leprosy Review|May 24, 2007
LeprosyBhushan Kumar, Ben Naafs, Sunil Dogra
Leprosy Review|January 31, 2004
Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofaziminePieter A M Schreuder, Ben Naafs
Leprosy Review|April 26, 2013
The leprosy mailing listSunil Deepak, Salvatore Noto, Ben Naafs, et al.
International Journal of Dermatology|January 26, 2013
Guidelines on the role of skin care in the management of mobile populationsLucinda Claire Fuller, Roderick Hay, Aldo Morrone, et al.
Clinics in Dermatology|January 17, 2016
Advances in leprosy immunology and the field application: A gap to bridgeVania Nieto Brito de Souza, Anand M Iyer, David A Lammas, et al.
Plos Neglected Tropical Diseases|January 5, 2011
Granulomatous reactivation during the course of a leprosy infection: reaction or relapseMaria Angela Bianconcini Trindade, Gil Benard, Somei Ura, et al.
Infection and Immunity|April 16, 2002
Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosisAnnemieke Geluk, Krista E van Meijgaarden, Kees L M C Franken, et al.
Pageof 1